Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to $1.6 million.

  • Ekso Bionics Holdings' Non-Current Deffered Revenue fell 1725.01% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 1725.01%. This contributed to the annual value of $1.9 million for FY2024, which is 1147.99% down from last year.
  • Latest data reveals that Ekso Bionics Holdings reported Non-Current Deffered Revenue of $1.6 million as of Q3 2025, which was down 1725.01% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Non-Current Deffered Revenue peaked at $2.2 million during Q4 2023, and registered a low of $1.0 million during Q3 2022.
  • In the last 5 years, Ekso Bionics Holdings' Non-Current Deffered Revenue had a median value of $1.6 million in 2023 and averaged $1.6 million.
  • In the last 5 years, Ekso Bionics Holdings' Non-Current Deffered Revenue crashed by 3418.49% in 2022 and then skyrocketed by 11017.44% in 2023.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Non-Current Deffered Revenue stood at $1.5 million in 2021, then plummeted by 30.03% to $1.0 million in 2022, then surged by 110.17% to $2.2 million in 2023, then fell by 11.48% to $1.9 million in 2024, then dropped by 15.05% to $1.6 million in 2025.
  • Its Non-Current Deffered Revenue was $1.6 million in Q3 2025, compared to $1.7 million in Q2 2025 and $2.0 million in Q1 2025.